Blue Jet Healthcare has niche appeal; review it after listing

With the global situation being volatile due to war and inflation, long-term investors interested in investing in a small niche chemicals business can review it after listing.


The company has a portfolio of 43 commercialised products with long-standing and multi-year contracts with MNCs. Its top five customers contribute 75% of its revenues. It has a production capacity of 1,000 kilolitres across its three plants in Maharashtra with expansion planned to take it to 1,500 kl.

ET Intelligence Group: Navi Mumbai-based Blue Jet Healthcare (BJH) is a pharma and healthcare ingredient company. The public issue is entirely an offer for sale in which the promoter family is diluting 14% of its stake. Hence, no money is coming into the company.Business: Established in 1968, BJH is engaged in the contract development and manufacture of contrast media intermediates (that are used in medical imaging) – earning 70% of its

  • SAVE

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

  • ​Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-​

Source link

Leave a comment